In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CVS Health Corp.

www.cvs.com

Latest From CVS Health Corp.

US FDA Questions Valisure’s Zantac Carcinogenicity Findings

As ranitidine suspensions and recalls mount worldwide, US agency says heat of pharmacy lab's test made nitrosamine levels appear high.

Manufacturing Quality

CVS, Walgreen Suspend OTC Ranitidine Sales As FDA Investigates Contamination

CVS, Walgreen suspend sales of brand and store brand ranitidine OTCs while Sanofi confirms it is not recalling Zantac in the US and has no plans to cease manufacturing or distributing.
OTC Drugs Recalls

CVS Reformulating Own-Brand Sunscreens Without Alleged Coral Killers

“CVS Pharmacy is highly attuned to our customers’ evolving needs and their desire for products that are more sustainable while still being efficacious,” says CVS Health’s George Coleman, senior vice president of merchandising. The retailer is committed to eliminating oxybenzone and octinoxate from CVS-branded sunscreens with SPFs less than 50 by the end of 2020.

Retail Business Strategies

Perrigo Prioritizes Innovating First After Following OTC Brands To Market

Perrigo’s "national brand better" approach includes adding "better" value to generic equivalents that branded aren't offering, says President and CEO Murray Kessler. Prevacid 24 HR acquisition puts Perrigo at top of 15-mg lansoprazole PPI brand sales as well as in the generics market.

OTC Drugs Commercial
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register